Learning Objectives:

• Understand the therapeutic potential and toxicity profile of antibody-drug conjugates (ADCs)
• Recognize, prevent, and manage ADC-induced oral mucositis
• Understand the patient's perception of mucositis and integrate patient-reported outcomes into supportive care planning

Agenda:

• Introduction – Prof. Paolo Bossi and Prof. Florian Scotté (Co-Chairs)
• Antibody-drug Conjugates: Clinical Data and On-target/Off-tumor Toxicities – Dr. Barbara Pistilli
• Prevention and Treatment of ADC-induced Mucositis: Back to the Past? – Dr. Emmanuelle Vigarios
• The Patient’s Point of View on Oral Mucositis – Dr. Helen Bulbeck
• Q&A

This webinar was made possible by an unrestricted grant from Daiichi Sankyo Europe/Astra Zeneca.